buthionine sulfoximine and glutathione synthesis inhibitor Combined inhibition of de novo nucleotide biosynthesis is synthetically lethal in glioblastoma sulfoximine, an inhibitor of – Cited in 26 publications Sigma-Aldrich ʟ-Buthionine-sulfoximine, CAS 83730-53-4, ≥97%
Sigma Aldrich Buthionine sulfoximine, CAS 83730 53 4, 97% (TLC) 500 mg Sigma Aldrich Buthionine sulfoximine, CAS 5072 26 4, 99.0% (TLC) 250 mg buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S Transferase Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () Preclinical evaluation of azathioprine plus The transsulfuration pathway connects methionine and glutathione Download Scientific Diagram Buthionine Sulphoximine New Drug Approvals
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11



